With 1 million new cases and 200,000 children dead each year, Tuberculosis (TB) is now the leading cause of death from infectious diseases for children of all ages globally (UNICEF). ImproViTB is among the first pediatric clinical studies in the Central African region aimed at improving the clinical outcome and quality of life of children with pulmonary tuberculosis through a standard antituberculosis treatment supplemented with vitamin D.
This project is lead by a consortium of research institutions and universities from 4 Central African countries (Republic of Congo, Democratic Republic of Congo, Cameroon and Gabon) and 3 European countries, coordinated by CANTAM (Prof. Francine Ntoumi), the Network of Excellence in clinical research for Central African region.
SEARCH
SEARCH (SouthErn Africa Regulatory for Clinical researcH) is a consortium of Southern African countries (Mozambique, Swaziland, Lesotho and Botswana) and European Union, aimed to increase the capacity of the National Regulatory Authorities to oversight clinical trials for new, safer and more effective medicines to treat the diseases affecting the Southern African region. The consortium is coordinated by TESA, the Network of Excellence in clinical research for Southern African region, lead by Dr. Eusebio Macete.
INTEGRATION+
INTEGRATION+ is an implementation research focused on malaria in pregnancy, with the potential to change national health prevention policies to protect an additional 13 million pregnant women each year from malaria. A consortium of universities and research institutions from 6 African countries and 2 European countries applied to fund this project to European Commission (EDCTP) and USA (PMI).
AfriEthique
A European-African partnership aimed at improving the ethics and regulatory capacity of clinical research in Central African countries has successfully proposed its project (AfriHetique) to the European Commission (EDCTP). The partnership is coordinated by CANTAM, the Network of Excellence in clinical research for Central African region, lead by Prof. Francine Ntoumi.
R-Evolution Sierra Leone
R-Evolution Worldwide Sierra Leone is a Local Voluntary Organization of Sierra Leoneans established to help and support vulnerable children, youth, women and communities to build a brighter future in changing lives for sustainable development. The regulatory process of accreditation to the Ministry and national authorities has been completed and this community based organization is starting its activities.
EXCO2019, the first and only global expo dedicated to the players active in the field of development cooperation
R-Evolution Worldwide Community Interest Company joined in EXCO2019, the first and only global expo dedicated to the innovative solutions provided by the actors of development cooperation: national and international agencies, governments, financial institutions, civil society and in particular, the private sector.
During EXCO2019, the players active in the field and those willing to enter development cooperation, had the possibility to meet financial Institutions, Government representatives, development agencies and international organizations, in order to engage in new business relationships aimed at creating partnerships to find solutions for sustainable development.
Malaria incidence stopped to decrease and begun to increase, especially in the 10 countries with the highest burden of malaria
R-Evolution Worldwide Community Interest Company participated as observer to the 15th WHO meeting of the Malaria Policy Advisory Committee (MPAC). The meeting highlighted how in the last couple of years the malaria incidence stopped to decrease and begun to increase, especially in the 10 countries with the highest burden of malaria. According to the World malaria report 2018, indeed, there were 219 million cases of the disease in 2017, compared to 217 million the year before. Every two minutes, a child dies of malaria. In 2017, the estimated global tally of malaria deaths stood at 435.000. All the 10 countries with the highest malaria burden are in Africa: Burkina Faso, Cameroon, Democratic Republic of the Congo, Ghana, Mali, Mozambique, Niger, Nigeria, Uganda and United Republic of Tanzania.
Liberia
With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union agency EDCTP approved for funding another new project: “LiberHetica: increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes …”. A great team lead by Liberian institutional rapresentatives made this come true, therefore I would like to thank Dr. Bolay Fotorma, Jemee Tegli, Dr. Stephen B. Kennedy, Gloria Mason, and Cecilia Morris.
The way to build bridges instead of walls is still long.
The way to build bridges instead of walls is still long, but I am happy to have got European Union funding for this project. Africlinique project aims to increase the capacity to oversight clinical trials addressing deadly diseases in Central African countries (specifically Republic of the Congo, Democratic Republic of the Congo, Cameroon and Gabon). This achievement was made possible thanks to the exciting proactiveness and invaluable collaboration of a Central African team lead by Prof. Francine Ntoumi, already coordinator of Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM).
Working on an idea for a brand new project
The ATTENTION project is aimed to improve the access to effective health services for the children in the orphanages and Interim Care Centers (ICCs) of Sierra Leone.
Indeed there is a huge lack of healthcare references for the children hosted in these facilities.
It is planned to finance this project by a call proposal to the Small Charities Challenge Fund (UKAid – DFID), by establishing an ad-hoc applying consortium.